Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Terbenafine Hydrochloride Bilayer Nail Lacquer

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2011 - Volume 15, Number 1
View All Articles in Issue

Page(s):  72

Terbenafine Hydrochloride Bilayer Nail Lacquer Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Terbenafine Hydrochloride Bilayer Nail Lacquer. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, terbenafine hydrochloride, nail fungus, fungal infection, antifungal agent, topical administration

Related Categories: FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Terbenafine Hydrochloride Bilayer Nail Lacquer
Allen Loyd V Jr
Jan/Feb 2011
Pg. 72

Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish
Allen Loyd V Jr
Mar/Apr 2022
Pg. 142

A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis
Turner Rob
, Weaver Sean, Caserta Francesco, Brown Marc B
Jan/Feb 2016
Pg. 71-80

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Ciclopirox 10% in Isopropyl Alcohol Nail Solution
Allen Loyd V Jr
Mar/Apr 2010
Pg. 152

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications
Dharmian Jose Prakash
, Sathiyaseelan Iraniammal, Renganathan Akshaya, Mubees Alamaan Mohamed, Naser Mohammed Yasin Abdul, Ramkrishnan Prakash, Arumugam Somasundaram
Nov/Dec 2023
Pg. 494-502

Terbinafine Hydrochloride 25-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2006
Pg. 145

A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
Nov/Dec 2022
Pg. 480-488

Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date
Gautam Pradeep
, Light Bob, Purvis Troy
Mar/Apr 2017
Pg. 154-159

Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson
, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Nov/Dec 2018
Pg. 516-526

Basics of Compounding for Fungal Sinusitis
Allen Loyd V Jr
Jul/Aug 2004
Pg. 289-291

Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E
, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017
Pg. 22-27

Tolnaftate 1% Antifungal Microemulsion
Allen Loyd V Jr
May/Jun 2008
Pg. 268

Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
Jul/Aug 2011
Pg. 308-315

Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 512

Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2013
Pg. 502

Compounding for Treatment of Equine Infectious Diseases: An Overview
Bramwell Bethany L
Nov/Dec 2011
Pg. 450-457

Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration
Trissel Lawrence A
, Xu Quanyun A
May/Jun 2005
Pg. 238-241

Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig
, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008
Pg. 156-160

Return to Top